1. Home
  2. PEN vs KT Comparison

PEN vs KT Comparison

Compare PEN & KT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PEN
  • KT
  • Stock Information
  • Founded
  • PEN 2004
  • KT 1981
  • Country
  • PEN United States
  • KT South Korea
  • Employees
  • PEN N/A
  • KT N/A
  • Industry
  • PEN Medical/Dental Instruments
  • KT Telecommunications Equipment
  • Sector
  • PEN Health Care
  • KT Telecommunications
  • Exchange
  • PEN Nasdaq
  • KT Nasdaq
  • Market Cap
  • PEN 9.0B
  • KT 9.8B
  • IPO Year
  • PEN 2015
  • KT 1999
  • Fundamental
  • Price
  • PEN $242.93
  • KT $20.40
  • Analyst Decision
  • PEN Strong Buy
  • KT
  • Analyst Count
  • PEN 16
  • KT 0
  • Target Price
  • PEN $300.47
  • KT N/A
  • AVG Volume (30 Days)
  • PEN 531.0K
  • KT 924.9K
  • Earning Date
  • PEN 07-29-2025
  • KT 08-25-2025
  • Dividend Yield
  • PEN N/A
  • KT 2.27%
  • EPS Growth
  • PEN 915.21
  • KT N/A
  • EPS
  • PEN 3.74
  • KT 1.75
  • Revenue
  • PEN $1,280,152,000.00
  • KT $18,077,204,461.00
  • Revenue This Year
  • PEN $14.60
  • KT $5.83
  • Revenue Next Year
  • PEN $14.24
  • KT N/A
  • P/E Ratio
  • PEN $64.87
  • KT $21.99
  • Revenue Growth
  • PEN 12.92
  • KT 0.13
  • 52 Week Low
  • PEN $160.18
  • KT $13.18
  • 52 Week High
  • PEN $310.00
  • KT $21.61
  • Technical
  • Relative Strength Index (RSI)
  • PEN 50.26
  • KT 47.38
  • Support Level
  • PEN $225.48
  • KT $20.76
  • Resistance Level
  • PEN $261.81
  • KT $21.15
  • Average True Range (ATR)
  • PEN 6.51
  • KT 0.33
  • MACD
  • PEN 2.63
  • KT -0.13
  • Stochastic Oscillator
  • PEN 48.03
  • KT 49.76

About PEN Penumbra Inc.

Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. It operates as one reportable segment and its business activity consists of the design, development, manufacturing and marketing of inventive medical products.

About KT KT Corporation

KT is South Korea's largest fixed-line telecom operator, with around 11.5 million fixed-line broadband customers and 9.4 million IPTV customers, and is the second-largest wireless operator with 26 million subscribers. Additionally, it has a number of nontelecom businesses, including real estate, payment processing, artificial intelligence, and IDC/cloud services, many of which are the focus of its growth strategy. The company was formed from the previously government-owned, monopoly telecom business and was listed in 1998. After selling its mobile business in 1994 (forming its mobile competitor, SK Telecom) KT created its own mobile operator in 1997.

Share on Social Networks: